What’s the scoop on the Mr Whippy decision?
Despite “convincing arguments” against the strength of the evidence of use submitted by Unilever Plc, following the close-cut decision of the IPO on the 11 November 2019, the applicants’
Read more
Sufficiency at the UK Supreme Court in Regeneron Pharmaceuticals Inc v Kymab Ltd
The UK Supreme Court handed down the judgment in a much anticipated biotech decision on 24 June. The Court found that Regeneron’s patents are invalid for lack of sufficient disclosure.
Read more
Drug repurposing to treat COVID-19
Practical, legal and moral implications where research involves patent-protected drugs One of the big talking points at present is how we can get back to living our lives in a
Read more
Sources of funding for innovation, and innovators, in the wake of COVID-19 and beyond
Sourcing funding for innovation is currently at the forefront of many businesses’ agenda in response to the current global pandemic. While it is an uncertain time for many, there are
Read more Akebia and Fibrogen – Lord Justice Arnold applies “Doctrine of Equivalents”
In this judgment at the High Court, Lord Justice Arnold stepped down from the Court of Appeal to the High Court to hear the case. His findings on infringement may
Read more
Green innovation and IP post-COVID-19: part one
Part one – green energy The National Grid confirmed recently that the UK has completed more than a full month without power input from the country’s coal-fired power stations. With
Read more
Intellectual property for start-ups in a post-COVID world: part five – managing know-how and trade secrets
This series of articles explores the effect of COVID-19-related disruption on start-ups’ management and monetisation of intellectual property (IP), giving practical guidance to start-ups to improve and preserve their position
Read more
Progressing innovation outside the lab: part three, physics and engineering innovation
Lab-based scientists may not be able to access their workspace during lockdown, but there are things that can be done remotely to further an IP programme. In part three of our series, “Progressing innovation outside the lab”, we outline strategic tasks that physics and engineering-focused researchers and scientists can complete to further intellectual property during time away from the lab.
Read more Intellectual property for start-ups in a post-COVID world: part four – patenting software
Intellectual property for start-ups in a post-COVID world: part four – patenting software This series of articles explores the effect of COVID-19-related disruption on start-ups’ management and monetisation of intellectual
Read more
Patent offices shut down computer inventorship: time to reboot?
At last July’s joint UK IPO and WIPO Conference on artificial intelligence and intellectual property (AI: decoding IP), one of the more lively sessions was on the topic of ownership
Read more
Innovation outside the lab – part two, software/electronics innovation
Lab-based scientists may not be able to access their workspace during lockdown, but there are things that can be done remotely to further an IP programme. In part two of
Read more
